Patent Assignment
Reel/Frame 054975/0183
Change of Name
Recorded: 2021-01-12
Pages: 6
Assignor
PORTOLA PHARMACEUTICALS, INC.
Executed: 2020-10-15
Assignee
PORTOLA PHARMACEUTICALS, LLC
270 E. GRAND AVE., SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(107)
Methods of Treatment with Syk Inhibitors
PCT:
PCT/US2005/013006 ↗
Protein Kinase Inhibitors
PCT:
PCT/US2008/073216 ↗
Inhibitors of Syk Protein Kinase
PCT:
PCT/US2009/002401 ↗
Inhibitors of Protein Kinases
PCT:
PCT/US2009/002420 ↗
Inhibitors of Protein Kinases
PCT:
PCT/US2009/002512 ↗
Combination Therapy with 4-(3-(2H-1,2,3-Triazol-2-Yl)Phenylamino)-2-((1R,2S)-2-Aminocyclohexylamino)Pyrimidine-5-Carboxamide
PCT:
PCT/US2011/054233 ↗
Combination Therapy of 4-(3-(2H-1,2,3-Triazo-2-Yl)Phenylamino)-2-((1R,2S)-2-Aminocyclohexylamino)Pyrimidine-5-Carboxamide and Fludarabine
PCT:
PCT/US2011/054351 ↗
Combination Therapy of 4-(Cyclopropylamino)-2-(4-(4-(Ethylsulfonyl)Piperazin-1-Yl)Phenylamino)Pyrimidine-5-Carboxamide and Fludarabine
PCT:
PCT/US2011/054373 ↗
Oxypyrimidines as Syk Modulators
PCT:
PCT/US2011/058822 ↗
Benzamides and Nicotinamides as Syk Modulators
PCT:
PCT/US2011/058826 ↗
Pyrazine Kinase Inhibitors
PCT:
PCT/US2012/066468 ↗
Selective Kinase Inhibitors
PCT:
PCT/US2012/066470 ↗
Bicyclic Dihydropyridone Kinase Inhibitors
PCT:
PCT/US2013/000224 ↗
Bicyclic Oxa-Lactam Kinase Inhibitors
PCT:
PCT/US2013/000225 ↗
Substituted Picolinamide Kinase Inhibitors
PCT:
PCT/US2013/045987 ↗
1,2,4-Triazine-6-Carboxamide Kinase Inhibitors
PCT:
PCT/US2013/046006 ↗
Substituted Pyrimidinyl Kinase Inhibitors
PCT:
PCT/US2013/063942 ↗
Cyclohexanediamine Compounds and Methods for Their Preparation
PCT:
PCT/US2014/027711 ↗
Cerdulatinib for the Treatment of B-Cell Malignancies
PCT:
PCT/US2016/034861 ↗
Cerdulatinib for Treating Myeloma
PCT:
PCT/US2016/046862 ↗
Cerdulatinib for Treating Hematological Cancers
PCT:
PCT/US2016/064824 ↗
Methods of Use and Pharmaceutical Compositions of a Selective Syk Inhibitor
PCT:
PCT/US2019/021402 ↗
Synthesis of Cerdulatinib
PCT:
PCT/US2019/030635 ↗
Methods for Treating Lymphoma
PCT:
PCT/US2019/030690 ↗
Solid Forms of Cerdulatinib
PCT:
PCT/US2019/030717 ↗
Methods of Treatment with Syk Inhibitors
Protein Kinase Inhibitors
Inhibitors of Protein Kinases
Inhibitors of Syk and Jak Protein Kinases
Inhibitors of Protein Kinases
Methods of Treatment with Syk Inhibitors
Inhibitors of Syk and Jak Protein Kinases
Inhibitors of Syk and Jak Protein Kinases
Benzamides and Nicotinamides as Syk Modulators
Inhibitors of Protein Kinases
Inhibitors of Protein Kinases
Inhibitors of Syk and Jak Protein Kinases
Substituted Pyrazine-2-Carboxamide Kinase Inhibitors
Combination Therapy with 4-(3-(2H-1,2,3-Triazol-2-Yl)Phenylamino)-2-((1R,2S)-2-Aminocyclohexylamino)Pyrimidine-5-Carboxamide
Application:
13/823,699 →
Publication:
US 2013/0244963
Combination Therapy of 4-(3-(2H-1,2,3-Triazo-2-Yl)Phenylamino)-2-((1R,2S)-2-Aminocyclohexylamino)Pyrimidine-5-Carboxamide and Fludarabine
Application:
13/823,710 →
Publication:
US 2013/0252917
Combination Therapy of 4-(Cyclopropylamino)-2-(4-(4-(Ethylsulfonyl)Piperazin-1-Yl)Phenylamino)Pyrimidine-5-Carboxamide and Fludarabine
Application:
13/823,714 →
Publication:
US 2013/0237493
1,2,4-Triazine-6-Carboxamide Kinase Inhibitors
Substituted Picolinamide Kinase Inhibitors
Application:
13/841,867 →
Publication:
US 2014/0113931
Oxypyrimidines as Syk Modulators
Application:
13/882,958 →
Publication:
US 2013/0317029
Inhibitors of Protein Kinases
Pyrazine Kinase Inhibitors
Selective Kinase Inhibitors
Application:
14/360,203 →
Publication:
US 2014/0323418
Bicyclic Dihydropyridone Kinase Inhibitors
Bicyclic Oxa-Lactam Kinase Inhibitors
Substituted Pyrimidinyl Kinase Inhibitors
Benzamides and Nicotinamides as Syk Modulators
Inhibitors of Protein Kinases
Inhibitors of Syk and Jak Protein Kinases
Cyclohexanediamine Compounds and Methods for Their Preparation
Application:
14/771,768 →
Publication:
US 2016/0009694
Benzamides and Nicotinamides as Syk Modulators
Cerdulatinib for Treating Myeloma
Application:
15/235,972 →
Publication:
US 2017/0042896
Cerdulatinib for the Treatment of B-Cell Malignancies
Application:
15/578,190 →
Publication:
US 2018/0147203
Cerdulatinib for Treating Hematological Cancers
Inhibitors of Protein Kinases
Synthesis of Cerdulatinib
Methods for Treating Lymphoma
Inhibitors of Protein Kinases
Cerdulatinib for Treating Myeloma
Application:
16/831,471 →
Publication:
US 2020/0222403
Cerdulatinib for Treating Hematological Cancers
Methods of Use and Pharmaceutical Compositions of a Selective Syk Inhibitor
Application:
16/979,075 →
Publication:
US 2021/0052582
Synthesis of Cerdulatinib
Solid Forms of Cerdulatinib
Methods of treatment with Syk inhibitors
Application:
60/563,710 →
Syk Inhibitors
Application:
60/956,643 →
Inhibitors of Protein Kinases
Application:
61/045,399 →
Inhibitors of Protein Kinases
Application:
61/045,406 →
Inhibitors of Protein Kinases
Application:
61/045,417 →
Inhibitors of Protein Kinases
Application:
61/045,499 →
Inhibitors of Protein Kinases
Application:
61/047,077 →
Inhibitors of Protein Kinases
Application:
61/120,341 →
Inhibitors of Protein Kinases
Application:
61/120,344 →
Inhibitors of Protein Kinases
Application:
61/120,346 →
Inhibitors of Protein Kinases
Application:
61/120,348 →
Combination Therapy with Inhibitors of Syk or Jak Protein Kinase
Application:
61/388,568 →
Combination Therapy of Inhibitor of Syk Protein Kinase and Fludarabine
Application:
61/388,570 →
Oxypyrimidines as Syk Modulators
Application:
61/409,060 →
Benzamides and Nicotinamides as Syk Modulators
Application:
61/409,077 →
Combination Therapy of Inhibitor of Syk Protein Kinase and Fludarabine
Application:
61/419,728 →
Selective Kinase Inhibitors
Application:
61/563,458 →
Pyrazine Kinase Inhibitors
Application:
61/563,466 →
1,2,4-Triazine-6-Carboxamide Kinase Inhibitors
Application:
61/663,499 →
Substituted Picolinamide Kinase Inhibitors
Application:
61/663,510 →
Bicyclic Dihydropyridone Kinase Inhibitors
Application:
61/706,681 →
Bicyclic Oxa-Lactam Kinase Inhibitors
Application:
61/706,712 →
Substituted Pyrimidinyl Kinase Inhibitors
Application:
61/711,170 →
Cyclohexanediamine Compounds and Methods for Their Preparation
Application:
61/792,318 →
Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates a Favorable Safety Profile and Evidence for Clinical Activity in Patients with Relapsed/Refractory B Cell Malignancies
Application:
62/168,530 →
Cerdulatinib for Treating of Multiple Myeloma
Application:
62/204,400 →
Cerdulatinib for Treating Hematological Cancers
Application:
62/263,582 →
Cerdulatinib for Treating of Multiple Myeloma
Application:
62/342,711 →
Cerdulatinib for Treating Hematological Cancers
Application:
62/342,727 →
Combinations with Cerdulatinib
Application:
62/342,755 →
Loss of IkappaBalpha Associated with Resistance to Cerdulatinib
Application:
62/371,145 →
Methods of Use and Pharmaceutical Compositions of a Selective Syk Inhibitor
Application:
62/641,094 →
Methods of Use and Pharmaceutical Compositions of a Selective Syk Inhibitor
Application:
62/663,999 →
Solid Forms of Cerdulatinib
Application:
62/667,226 →
Synthesis of Cerdulatinib
Application:
62/667,235 →
Methods for Treating Lymphoma
Application:
62/667,249 →
Methods for Treating Lymphoma
Application:
62/678,934 →
Methods for Treating Lymphoma
Application:
62/736,047 →
Synthesis of Cerdulatinib
Application:
62/822,714 →
Circulating B Cell Subpopulations in Indolent B Cell Lymphoma
Application:
63/030,095 →
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 25, 2005
From: ANDRE, PATRICK; PHILIPS, DAVID R.; HOMCY, CHARLES
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 016596/0898 →
Assignment of Assignor's Interest
Oct 27, 2008
From: SONG, YONGHONG; XU, QING; PANDEY, ANJALI
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 021740/0401 →
Assignment of Assignor's Interest
Dec 10, 2009
From: BAUER, SHAWN M.; JIA, ZHAOZHONG J.; SONG, YONGHONG; XU, QING
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 023637/0058 →
Assignment of Assignor's Interest
Dec 10, 2009
From: SONG, YONGHONG; XU, QING; BAUER, SHAWN M.; JIA, ZHAOZHONG J.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 023637/0197 →
Assignment of Assignor's Interest
Dec 29, 2009
From: JIA, ZHAOZHONG; VENKATARAMANI, CHANDRASEKAR; HUANG, WOLIN; MEHROTRA, MUKUND
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 023714/0299 →
Assignment of Assignor's Interest
Sep 22, 2011
From: BAUER, SHAWN M.; JIA, ZHAOZHONG J.; MEHROTRA, MUKUND; SONG, YONGHONG
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 026951/0444 →
Assignment of Assignor's Interest
Sep 22, 2011
From: BAUER, SHAWN M.; JIA, ZHAOZHONG J.; VENKATARAMANI, CHANDRASEKAR; SONG, YONGHONG
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 026951/0109 →
Assignment of Assignor's Interest
May 28, 2013
From: SINHA, UMA; PANDEY, ANJALI
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 030496/0585 →
Assignment of Assignor's Interest
May 28, 2013
From: SINHA, UMA; PANDEY, ANJALI
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 030496/0291 →
Assignment of Assignor's Interest
May 28, 2013
From: PANDEY, ANJALI; XU, QING; HUANG, WOLIN; JIA, ZHAOZHONG J.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 030496/0411 →
Assignment of Assignor's Interest
May 30, 2013
From: SINHA, UMA; PANDEY, ANJALI
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 030514/0352 →
Assignment of Assignor's Interest
Apr 23, 2015
From: JIA, ZHAOZHONG; VENKATARAMANI, CHANDRASEKAR; HUANG, WOLIN; MEHROTRA, MUKUND
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 035481/0922 →
Assignment of Assignor's Interest
Jun 15, 2018
From: PANDEY, ANJALI; COFFEY, GREGORY; LEEDS, JANET
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 046099/0573 →
Security Interest
Mar 18, 2019
From: PORTOLA PHARMACEUTICALS, INC.
To: HCR COLLATERAL MANAGEMENT, LLC
Reel/Frame 048633/0673 →
Release of Security Interest
Jul 2, 2020
From: HCR COLLATERAL MANAGEMENT, LLC
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 053120/0925 →
Assignment of Assignor's Interest
Jan 14, 2021
From: PORTOLA PHARMACEUTICALS, LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 054999/0218 →